---
$id: https://graph.org.ai/products/commodity/51202901
$type: Product
source: UNSPSC
code: "51202901"
title: "Abetimus"
class: "51202900"
classTitle: "Immunosupressant nucleic acids, nucleotides, and nucleosides"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Abetimus

**UNSPSC Code**: 51202901
**Class**: [Immunosupressant nucleic acids, nucleotides, and nucleosides](Immunosupressant nucleic acids, nucleotides, and nucleosides.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an immunosuppressant, a biological preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) F5Y7739G6U. World Health Organization schedules abetimus in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations, for tariff and trade purposes, schedule abetimus under HS 29349990 and SITC 51579. As of Q4 2014, ABETIMUS remains US FDA's Preferred Term for this commodity. For the most current information on WCO designations on abetimus and salts thereof, please see Committee proceedings HSC/53, NC2004B1b Ann. O/6 (2014).

